Dr Lu Li
Investment Analyst
| Healthcare
| Location: Sydney, AU
Lu focuses on healthcare investments, supporting the team with deal sourcing and screening, due diligence and investment monitoring.
She draws on her expertise in equity research and biomedical sciences to inform investment decisions and drive deal-term negotiations.
Before joining OneVentures, Lu interned as Biotech Equity Research analyst at CITIC Securities and worked as a scientific writer and technical consultant at DeepTech, covering biotech startups and advancements in biomedical research. She brings over seven years of academic research experience in biomedical sciences with a strong technical background in R&D.
Lu holds a Ph.D. in Pathobiology from the University of Connecticut where her research focused on infectious disease pathogenesis. She has completed Level 2 of the CFA program.
| PhD, Pathobiology